ÂÜÀòÂÒÂ×

Donald Payne, MBA, CPA has served as a Director at Ansun since April 2018. For the past 27 years, Mr. Payne has held senior operating and financial positions in early-stage biopharmaceutical and medical device companies. His operations experience includes authoring IND and IDE filings with the FDA, managing the US and non-US clinical trials in oncology, establishing cGMP manufacturing operations, and managing preclinical efficacy and toxicology programs. Mr. Payne has co-authored 9 scientific publications and is a co-inventor of two issued and one pending patent application. He has served as a director of public and private early-stage companies, including as the Chairman of the Audit Committee of a Nasdaq-listed company. As the chief financial officer of early-stage companies, he has participated in various public and private financings and listings on NYSE and Nasdaq. He currently consults with biopharmaceutical and medical device companies focused on oncology. Mr. Payne is a Summa Cum Laude graduate of Rice University with a Master's in Business Administration (1992) and a Summa Cum Laude graduate of Texas A&M University (1976) with a Bachelor's in Business Administration. Mr. Payne is a licensed CPA in Texas.